The increase of leukocytes as a new putative marker of low-grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome

Francesco Orio, Stefano Palomba, Teresa Cascella, Sebastiano Di Biase, Francesco Manguso, Libuse Tauchmanovà, Luciano G. Nardo, Donato Labella, Silvia Savastano, Tiziana Russo, Fulvio Zullo, Annamaria Colao, Gaetano Lombardi

Research output: Contribution to journalArticle

159 Citations (Scopus)

Abstract

White blood cell (WBC) count is a known risk factor for atherosclerotic vascular disease in adult women. Polycystic ovary syndrome (PCOS) is potentially a risk factor for atherosclerosis and cardiovascular disease. The aim of the present study was to investigate leukocyte count in PCOS. One hundred and fifty PCOS women matched for age and body mass index with 150 healthy women were enrolled. WBC count, C-reactive protein, and a complete anthropometrical, metabolic, and hormonal evaluation were performed in both groups. Serum insulin, glucose level, and lipid profile were also measured in each subject. WBC count was significantly higher (P <0.0001) in PCOS with (interquartile range in parentheses) 7260 (393) cells/mm3, compared with controls with 5220 (210) cells/mm3. C-reactive protein levels were significantly increased (P <0.0001) in PCOS with 2 (1) mg/liter compared with healthy women with 0.7 (0.8) mg/liter. In both groups, there was a significant (P <0.0001) linear correlation between WBC count and homeostasis model assessment score (PCOS, r = 0.94; controls, r = 0.91). Multiple linear regression analysis showed that other hormone levels are not predictors of leukocyte count both in PCOS and control women. In conclusion, our data demonstrate that PCOS women have an increased WBC count that correlates with homeostasis model assessment values.

Original languageEnglish
Pages (from-to)2-5
Number of pages4
JournalJournal of Clinical Endocrinology and Metabolism
Volume90
Issue number1
DOIs
Publication statusPublished - Jan 2005

Fingerprint

Polycystic Ovary Syndrome
Leukocyte Count
Leukocytes
Blood
Inflammation
C-Reactive Protein
Homeostasis
Linear regression
Regression analysis
Cells
Hormones
Insulin
Lipids
Glucose
Vascular Diseases
Linear Models
Atherosclerosis
Body Mass Index
Cardiovascular Diseases
Regression Analysis

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology, Diabetes and Metabolism

Cite this

The increase of leukocytes as a new putative marker of low-grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome. / Orio, Francesco; Palomba, Stefano; Cascella, Teresa; Di Biase, Sebastiano; Manguso, Francesco; Tauchmanovà, Libuse; Nardo, Luciano G.; Labella, Donato; Savastano, Silvia; Russo, Tiziana; Zullo, Fulvio; Colao, Annamaria; Lombardi, Gaetano.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 90, No. 1, 01.2005, p. 2-5.

Research output: Contribution to journalArticle

Orio, F, Palomba, S, Cascella, T, Di Biase, S, Manguso, F, Tauchmanovà, L, Nardo, LG, Labella, D, Savastano, S, Russo, T, Zullo, F, Colao, A & Lombardi, G 2005, 'The increase of leukocytes as a new putative marker of low-grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome', Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 1, pp. 2-5. https://doi.org/10.1210/jc.2004-0628
Orio, Francesco ; Palomba, Stefano ; Cascella, Teresa ; Di Biase, Sebastiano ; Manguso, Francesco ; Tauchmanovà, Libuse ; Nardo, Luciano G. ; Labella, Donato ; Savastano, Silvia ; Russo, Tiziana ; Zullo, Fulvio ; Colao, Annamaria ; Lombardi, Gaetano. / The increase of leukocytes as a new putative marker of low-grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome. In: Journal of Clinical Endocrinology and Metabolism. 2005 ; Vol. 90, No. 1. pp. 2-5.
@article{9a07c56a8eac4f0ca8ddf06e44667eb0,
title = "The increase of leukocytes as a new putative marker of low-grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome",
abstract = "White blood cell (WBC) count is a known risk factor for atherosclerotic vascular disease in adult women. Polycystic ovary syndrome (PCOS) is potentially a risk factor for atherosclerosis and cardiovascular disease. The aim of the present study was to investigate leukocyte count in PCOS. One hundred and fifty PCOS women matched for age and body mass index with 150 healthy women were enrolled. WBC count, C-reactive protein, and a complete anthropometrical, metabolic, and hormonal evaluation were performed in both groups. Serum insulin, glucose level, and lipid profile were also measured in each subject. WBC count was significantly higher (P <0.0001) in PCOS with (interquartile range in parentheses) 7260 (393) cells/mm3, compared with controls with 5220 (210) cells/mm3. C-reactive protein levels were significantly increased (P <0.0001) in PCOS with 2 (1) mg/liter compared with healthy women with 0.7 (0.8) mg/liter. In both groups, there was a significant (P <0.0001) linear correlation between WBC count and homeostasis model assessment score (PCOS, r = 0.94; controls, r = 0.91). Multiple linear regression analysis showed that other hormone levels are not predictors of leukocyte count both in PCOS and control women. In conclusion, our data demonstrate that PCOS women have an increased WBC count that correlates with homeostasis model assessment values.",
author = "Francesco Orio and Stefano Palomba and Teresa Cascella and {Di Biase}, Sebastiano and Francesco Manguso and Libuse Tauchmanov{\`a} and Nardo, {Luciano G.} and Donato Labella and Silvia Savastano and Tiziana Russo and Fulvio Zullo and Annamaria Colao and Gaetano Lombardi",
year = "2005",
month = "1",
doi = "10.1210/jc.2004-0628",
language = "English",
volume = "90",
pages = "2--5",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "1",

}

TY - JOUR

T1 - The increase of leukocytes as a new putative marker of low-grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome

AU - Orio, Francesco

AU - Palomba, Stefano

AU - Cascella, Teresa

AU - Di Biase, Sebastiano

AU - Manguso, Francesco

AU - Tauchmanovà, Libuse

AU - Nardo, Luciano G.

AU - Labella, Donato

AU - Savastano, Silvia

AU - Russo, Tiziana

AU - Zullo, Fulvio

AU - Colao, Annamaria

AU - Lombardi, Gaetano

PY - 2005/1

Y1 - 2005/1

N2 - White blood cell (WBC) count is a known risk factor for atherosclerotic vascular disease in adult women. Polycystic ovary syndrome (PCOS) is potentially a risk factor for atherosclerosis and cardiovascular disease. The aim of the present study was to investigate leukocyte count in PCOS. One hundred and fifty PCOS women matched for age and body mass index with 150 healthy women were enrolled. WBC count, C-reactive protein, and a complete anthropometrical, metabolic, and hormonal evaluation were performed in both groups. Serum insulin, glucose level, and lipid profile were also measured in each subject. WBC count was significantly higher (P <0.0001) in PCOS with (interquartile range in parentheses) 7260 (393) cells/mm3, compared with controls with 5220 (210) cells/mm3. C-reactive protein levels were significantly increased (P <0.0001) in PCOS with 2 (1) mg/liter compared with healthy women with 0.7 (0.8) mg/liter. In both groups, there was a significant (P <0.0001) linear correlation between WBC count and homeostasis model assessment score (PCOS, r = 0.94; controls, r = 0.91). Multiple linear regression analysis showed that other hormone levels are not predictors of leukocyte count both in PCOS and control women. In conclusion, our data demonstrate that PCOS women have an increased WBC count that correlates with homeostasis model assessment values.

AB - White blood cell (WBC) count is a known risk factor for atherosclerotic vascular disease in adult women. Polycystic ovary syndrome (PCOS) is potentially a risk factor for atherosclerosis and cardiovascular disease. The aim of the present study was to investigate leukocyte count in PCOS. One hundred and fifty PCOS women matched for age and body mass index with 150 healthy women were enrolled. WBC count, C-reactive protein, and a complete anthropometrical, metabolic, and hormonal evaluation were performed in both groups. Serum insulin, glucose level, and lipid profile were also measured in each subject. WBC count was significantly higher (P <0.0001) in PCOS with (interquartile range in parentheses) 7260 (393) cells/mm3, compared with controls with 5220 (210) cells/mm3. C-reactive protein levels were significantly increased (P <0.0001) in PCOS with 2 (1) mg/liter compared with healthy women with 0.7 (0.8) mg/liter. In both groups, there was a significant (P <0.0001) linear correlation between WBC count and homeostasis model assessment score (PCOS, r = 0.94; controls, r = 0.91). Multiple linear regression analysis showed that other hormone levels are not predictors of leukocyte count both in PCOS and control women. In conclusion, our data demonstrate that PCOS women have an increased WBC count that correlates with homeostasis model assessment values.

UR - http://www.scopus.com/inward/record.url?scp=19944426044&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=19944426044&partnerID=8YFLogxK

U2 - 10.1210/jc.2004-0628

DO - 10.1210/jc.2004-0628

M3 - Article

C2 - 15483098

AN - SCOPUS:19944426044

VL - 90

SP - 2

EP - 5

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 1

ER -